OmegaScore® - Personalized Omega-3 Testing in Whole Blood
OmegaScore® personalized omega-3 testing is available exclusively from Lipid Analytical Labs (Guelph, ON, Canada) and CanAlt (Toronto, ON, Canada, canaltlabs.com). They have acquired specialized paper strip technology that can be mailed for laboratory analysis for a fully personalized fatty acid profile. The OmegaScore® is a powerful indicator of the risk for sudden cardiac death based on published studies from the Harvard School of Public Health in the New England Journal of Medicine1. Furthermore, a high OmegaScore® is related to a reduced risk for "all-cause mortality2" and "cognitive deterioration with aging3"; all of which will be provided to you to interpret the report quickly.
If the lab results indicate a low OmegaScore®, individuals can initiate an increased intake of omega-3 fatty acids from food sources (e.g. fish/seafood) and supplements containing EPA/DHA. If the last intake modifications are done regularly, one can expect their Omega Score to be favourably altered to be in the low-risk zone for the above health conditions. Re-testing of the Omega Score can be done after 4-8 weeks to confirm entry into the "low risk" zones.
The OmegaScore® report is not intended as a medical report or medical advice from Lipid Analytical Laboratory, LLC. It is solely a measurement and calculation of various fatty acids based on the samples provided. "Risk Levels" are intended as a reference of height compared to recent academic research studies. Would you please consult a licensed health professional regarding your results or for advice on any dietary changes and supplementation that may be required?
Whole Blood Profiling
Easy to use spot cards require just a drop of blood for analysis to test for cardiac health, cognitive deterioration and other vital health markers.
Analytical Targets
Fatty acid methyl esters including but not limited to: Eicosapentaenoic Acid (EPA), Docosahexaenoic acid (DHA), Docosapentaenoic acid (DPA), Saturated, Monounsaturated, Polyunsaturated, Arachidonic acid (AA), Total Omega-3, Total Omega-6. Would you please inquire with regards to other fatty acids if required?
Analysis Platform
GC-FID
Method Summary
This method determines the fatty acid composition (including DHA, EPA, and DPA) of whole blood in relative (area %) values using a bonded polyglycol liquid phase in a flexible fused silica capillary column. The esterification of these fatty acids to fatty acid methyl esters is performed using an alkylation derivatization reagent. Methyl esters offer excellent stability and provide quick and quantitative samples for GC analysis. GC analysis offers a comprehensive profile that allows practitioners to accurately assess the content and shape of fatty acids in their oil products. Fatty acids are extracted in the presence of the internal standard using a priority solvent mixture. The fatty acid methyl esters are transmethylated. The resulting fatty acid methyl esters are then analyzed on an Agilent 7890B gas-liquid chromatography with a 60-m DB-23 capillary column (0.32 mm internal diameter) against their internal standard. Data is reported in % fatty acid methyl ester by weight.
Sample Requirement
- Small blood samples (a drop or two provided after using provided lancet on a finger, deposited on provided specialized absorbent pads.)
- Blood samples may alternatively be provided via appropriate medical receptacles.
Data Reporting
- Personalized OmegScore® report, CoA (pdf.)
- Data reported as % by weight
